Prior to the advent of targeted therapy, cytoreductive nephrectomy was associated with a 6-month improvement in overall survival in metastatic renal cell carcinoma. With the development of new and better targeted therapies for metastatic renal cell carcinoma, the appropriate use of cytoreductive...